IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment

News
2020
2019
Archive

August 5, 2020

IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment
July 28, 2020

Cleave Therapeutics Announces Commencement of a Phase I Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
July 27, 2020

scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission
July 22, 2020

Nouscom Highlights Cutting-Edge Science That Led to the Design of NOUS-209, A Potential Off-The-Shelf Neoantigen Cancer Vaccine for Tumors with Microsatellite Instability
July 22, 2020

Homology Medicines Appoints Jeff Poulton to the Board of Directors
July 17, 2020

Vor Biopharma Appoints Daniella Beckman to its Board of Directors
July 17, 2020

IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial
July 16, 2020

RareCyte® Announces the Orion™ Spatial Biology Platform with Breakthrough Technology for Same-Day Highly Multiplexed Tissue Analysis
July 16, 2020

Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 15, 2020

Vor Biopharma Appoints Dr. Christopher Slapak as Chief Medical Officer

1
2
3
…
66
Next Page »